The SARS-CoV2 pandemic has impacted society in very diverse ways. Many people have changed their habits due to lockdown, such as practising physical1
Hospital Clínic de Barcelona-IDIBAPS and Cellnex have today signed an agreement to launch a multicentre research project that will allow better under1
Active or past infection was detected among 11.2% of the Hospital Clinic staff that participated in the study.
These are the first results of a global clinical trial in which the Hospital Clinic and ISGlobal participate.
SARS-CoV-2 is a virus that affects people with respiratory diseases such as asthma, Chronic Obstructive Pulmonary Disease (COPD) or pulmonary fibrosi1
The prophylactic and serological studies will be performed on healthcare workers at Hospital Clínic of Barcelona.
A team formed by professionals from Hospital Clínic, Germans Trias i Pujol Research Institute and Hospital (IGTP) and the Faculty of Medicine and Hea1
